https://www.thebodypro.com/category/hiv-treatments-in-development
HIV Treatment Strategies

HIV Treatments in Development

The Latest

Long-Acting Antiretrovirals photo illo
Features

ATLAS, FLAIR, and the Upcoming Arrival of Long-Acting Injectable HIV Treatment

The likely launch of injectable cabotegravir/rilpivirine in early 2020 will be interesting, writes David Wohl, M.D. One big question: How smoothly will the rollout go?

Islatravir photo illo
Features

Islatravir Is Potent and Long-Lasting -- and May Be Having an Identity Crisis

This is clearly an antiretroviral not built for daily administration. But then what is it destined for?

Several Medication Pill Bottles On Table In Front Of Windows
Conference Coverage

Patients With HIV Should Think About How Many Pills They Take a Day

Taking more than five medications could be a problem. And many people with HIV are at risk of being on medication overload.

doctor drawing blood from patient
News

NIH, Gates Foundation Hatch Plan to Develop Affordable Gene Therapy for HIV, Sickle Cell Disease

The new public-private partnership will put $200 million toward finding eventual cures for two of the world's most pervasive diseases.

Medical: Pills and Syringe
Conference Coverage

Two-Drug Regimen Is Being Studied as a Long-Acting Injectable. But Does It Work as a Daily Pill?

New analysis of the LATTE trial shows the two drugs cabotegravir and rilpivirine may also work as a daily oral formulation, which could be a bridge therapy for people who miss an injectable appointment.

Full panel for HIV Treatment Research: New Drugs and More Efficient Regimens press conference
Conference Coverage

What's New in HIV Treatment: A Report on Updates from IAS 2019

Researchers reported hopeful news on regimens with lower treatment burdens and newly developed antiretrovirals.

Mexico City's Downtown At Twilight
Conference Coverage

IAS 2019: What to Expect in HIV Science

Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.

Physician or nurse giving injection in patient's arm
News

Study Finds Long-Acting HIV Meds Are Acceptable to Many People, but Differences Exist Among Groups

People with college education, gay and bisexual men, and people who struggle to make clinic visits were more likely to prefer the long-acting option.

Close up of sneakers walking up stairs
News

This Week in HIV Research: One Step at a Time

June 13, 2019: Integrated stepped alcohol treatment in HIV clinics; cytokines, inflammation, and heart risk; impact of CCR5 gene editing on lifespan; the costs of "test and treat" for hepatitis C.